TTrialPathMatch Me to Trials
← Back to trials
RecruitingMigraine

Study of EVO756 in Adults With Migraine

Eligible age

18–64 yrs

Accepts

All genders

Locations

18 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

Sponsor: Evommune, Inc.

Where it's recruiting

Arizona

Chandler

California

Buena Park · Fresno · La Jolla · Los Angeles …

Colorado

Denver

Connecticut

New Haven · Stamford

Florida

Jacksonville · Miami · Orlando · Tampa …

Georgia

Atlanta · Decatur

Massachusetts

Foxborough · Westborough

Michigan

Ann Arbor · Farmington Hills

Nebraska

Papillion

New Jersey

Toms River

New York

Amherst

North Carolina

Asheville · Raleigh

Source: ClinicalTrials.gov · NCT07616128 · last updated 2026-11-13

Study of EVO756 in Adults With Migraine · TrialPath